Hormonbehandling i klimakteriet kan ge risk för ovarialcancer
Engelsk titel: Hormone therapy in menopause can increase the risk of ovarian cancer
Läs online
Författare:
Flöter Rådestad, Angelique
Email: angelique.floter-radestad@ki.se
Språk: Swe
Antal referenser: 25
Dokumenttyp:
Artikel
UI-nummer: 16077630
Sammanfattning
Risk of ovarian cancer should be added to the list of adverse effects of hormone replacement therapy (HRT). However
there is no need for change in clinical recommendations. The recommendation today is to prescribe the lowest dose and
shortest time of HRT for menopausal symptom relief. Our clinical approach should be to include among other riskfactors the
risk of one extra case of ovarian cancer/1000 users for 5 years of HRT versus reduced quality of life without HRT for each
woman.